Risk of metachronous neoplastic lesions during post‐polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy. Issue 8 (25th March 2021)

• Record Type: Journal Article
• Authors: Sekiguchi, Masau; Kakugawa, Yasuo; Takamaru, Hiroyuki; Yamada, Masayoshi; Sakamoto, Taku; Saito, Yutaka; Matsuda, Takahisa
• Is Part Of: Journal of gastroenterology and hepatology. Volume 36:Issue 8(2021)
• Page Start: 2230
• Page End: 2238
• Publication Date: 2021-03-25
• Subjects: advanced colorectal neoplasia -- colonoscopy -- colorectal cancer screening -- polypectomy -- surveillance; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.15471
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: The evidence of associations between some types of advanced colorectal neoplasia (ACN) at baseline and the risk of metachronous neoplasia is inconsistent. This study aimed to elucidate the incidence of metachronous neoplasia during post‐polypectomy surveillance in individuals with ACN at baseline and examine the risk factors for its high incidence. Methods: Data from individuals who underwent endoscopic resection for ACN and received surveillance colonoscopy were analyzed. Data from individuals with no neoplastic lesions at baseline were used as reference. The incidence of metachronous ACN and clinically significant neoplasia (ACN and nonadvanced adenomas sized ≥ 5 mm) were evaluated. Risk factors for the higher incidence of these lesions were examined in individuals with ACN at baseline. Results: During the median follow‐up period of 61.8 months, metachronous ACN and nonadvanced adenomas sized ≥ 5 mm were detected in 9.6% and 32.4% of individuals with ACN at baseline ( n = 136), respectively. The cumulative incidence of metachronous ACN and clinically significant neoplasia in individuals with ACN at baseline (3‐year incidence: 5.5% and 16.9%, respectively) was higher than that in individuals with no neoplastic lesions at baseline ( P < 0.01 for both). The presence of advanced histology at baseline, ≥ 5 neoplastic lesions at baseline, and family history of colorectal cancer were identified as risk factors for the higher incidence of clinically significant neoplasia. Conclusions: The relatively high incidence of metachronous neoplasia in individuals with ACN at baseline was confirmed; careful surveillance is required for these individuals, particularly in those with the risk factors.